Cecal Diseases  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00458809: Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer

Completed
1
16
US
oxaliplatin
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Carcinoma of the Appendix, Colorectal Cancer, Primary Peritoneal Cavity Cancer
11/07
11/07
NCT00019773: Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Completed
1
US
capecitabine, oxaliplatin
National Cancer Institute (NCI)
Carcinoma of the Appendix, Colorectal Cancer, Small Intestine Cancer
 
 

Download Options